Skip to main content

Nicotine Mini

NDC 69842-964 · CVS Pharmacy

Generic namenicotine polacrilex
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength4 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

69842-964-08 — 4 BOTTLE, PLASTIC in 1 BOX (69842-964-08) / 27 LOZENGE in 1 BOTTLE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69842-595 — nicotine polacrilex, 69842-605 — nicotine polacrilex, 69842-608 — Nicotine Polacrilex, 69842-609 — Nicotine Polacrilex, 69842-662 — nicotine polacrilex, 69842-828 — nicotine, 69842-858 — nicotine polacrilex, 69842-932 — nicotine polacrilex, 69842-934 — Nicotine Polacrilex, 69842-957 — nicotine polacrilex, 69842-976 — nicotine polacrilex, 70000-0341 — Nicotine Polacrilex, 70000-0342 — Nicotine Polacrilex, 70000-0343 — Nicotine Polacrilex, 70000-0344 — Nicotine Polacrilex, 70000-0345 — Nicotine Polacrilex, 70000-0346 — Nicotine Polacrilex, 70000-0347 — Nicotine Polacrilex, 70000-0348 — Nicotine Polacrilex, 70000-0510 — Nicotine Transdermal System, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels